Metraipolis › archive › dc_5bb21fa5422c

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899499
DOI
10.3390/cancers18060894
License (as archived)
solo-consultazione
Archived
2026-11-04T23:29:37.143Z
SHA-256 of the archived text
afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a
Stable URL of this page
https://metraipolis.com/documento/dc_5bb21fa5422c

How to cite

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499 — Europe PMC (en), https://europepmc.org/article/MED/41899499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5bb21fa5422c (Metraipolis archive dc_5bb21fa5422c, sha256 afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a)
BibTeX
@misc{dc5bb21fa5422c,
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899499},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5bb21fa5422c; sha256 afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899499. Agents can read the archived copy with the MCP tool read_document.